WHO ICTRP trial
Study of tumor imaging by positron emission tomography agent 68Ga-SGC8
ChiCTR-DDD-16010114 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-DDD-16010114 |
|---|---|
| Public title | Study of tumor imaging by positron emission tomography agent 68Ga-SGC8 |
| Scientific title | Study of tumor imaging by positron emission tomography agent aptamer 68Ga-SGC8 |
| Primary sponsor | First Affiliated Hospital, Fourth Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | solid tumor |
| Interventions | Gold Standard:;Index test: |
| Registration date | Dec 8, 2016 |
| Target size | Target condition:0;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: